MOUs in the Biotechnology Industry

35 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Memorandum of Understanding between Oncocyte Corporation and Bio-Rad Laboratories, Inc. for RUO Assay Pilot Commercialization
MOUs
OncoCyte Corp
Biotechnology
2024
Letter Agreement between VBI Vaccines Inc. and Brii Biosciences Limited Regarding License and Asset Purchase Conditions
MOUs
VBI Vaccines Inc
Biotechnology
NY
2024
Memorandum of Understanding Between Vitro Biopharma, Inc. and Dr. Jack Zamora for International Clinical Research Collaboration
MOUs
VITRO DIAGNOSTICS INC
Biotechnology
2024
Memorandum of Understanding Regarding Expansion of Healios Territory and Clinical Supply for ARDS between ABT Holding Company and Healios K.K.
MOUs
ATHERSYS, INC
Biotechnology
2023
Memorandum of Understanding Between Vitro Biopharma, Inc. and Dr. Jack Zamora for International Clinical Research Collaboration
MOUs
VITRO DIAGNOSTICS INC
Biotechnology
2023
Binding Memorandum of Understanding Between Statera Biopharma, Inc. and Holobeam Technologies, Inc.
MOUs
CLEVELAND BIOLABS INC
Biotechnology
DE
2022
Memorandum of Understanding among Veracyte, Inc. and HalioDx Shareholders Regarding Proposed Acquisition
MOUs
VERACYTE, INC.
Biotechnology
NY
2021
Memorandum of Understanding Among Caribou Biosciences, University of Vienna, and Regents of the University of California Regarding Cas9 License
MOUs
Caribou Biosciences, Inc.
Biotechnology
2021
Memorandum of Understanding Between Windlas Biotech Private Limited and Mateon Therapeutics, Inc. for Artemisinin Co-Development
MOUs
MATEON THERAPEUTICS INC
Biotechnology
2020
Memorandum of Understanding Between Vitro Diagnostics Inc. and Global Institute of Stem Cell Therapy and Research, Inc. for COVID-19 Therapy Collaboration
MOUs
VITRO DIAGNOSTICS INC
Biotechnology
2020
Memorandum of Understanding between Wuxi Huishan Economic Development Zone and CASI Pharmaceuticals, Inc.
MOUs
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Memorandum of Understanding for Private Placement between Biostage, Inc. and Bin Zhao
MOUs
Biostage, Inc.
Biotechnology
2017
Memorandum of Understanding Between Biostage, Inc. and First Pecos, LLC for Equity Investment and Board Representation
MOUs
Biostage, Inc.
Biotechnology
2017
Amendment to Memorandum of Understanding between Vitro Diagnostics, Inc. and Caribbean GC Development Fund
MOUs
VITRO DIAGNOSTICS INC
Biotechnology
2017
Memorandum of Understanding Between Vitro Diagnostics, Inc. and Caribbean GC Development Fund Ltd. Regarding $1.7 Million Debt Investment and Related Agreements
MOUs
VITRO DIAGNOSTICS INC
Biotechnology
2017
Binding Memorandum of Understanding Between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte Ltd (July 28, 2016)
MOUs
PharmaCyte Biotech, Inc.
Biotechnology
2016
Memorandum of Understanding for Research and License Agreement between Yissum and Immune Pharmaceuticals Ltd.
MOUs
IMMUNE PHARMACEUTICALS INC
Biotechnology
2015
Memorandum of Understanding for Research and License Agreement between Yissum and Immune Pharmaceuticals Ltd.
MOUs
IMMUNE PHARMACEUTICALS INC
Biotechnology
2015
Memorandum of Understanding Regarding Compensation Between Nuvilex, Inc. and Dr. Robert F. Ryan
MOUs
PharmaCyte Biotech, Inc.
Biotechnology
2014
Letter of Intent for Clinical Trial Services Between Radius Health, Inc. and Nordic Bioscience A/S
MOUs
Radius Health, Inc.
Biotechnology
2013
Second Memorandum of Understanding Regarding Sublease Between University of Tennessee Research Foundation and GTx, Inc. (as Amended July 20, 2009)
MOUs
GTX INC
Biotechnology
2013
Letter of Intent for Clinical Trial Services Between Radius Health, Inc. and Nordic Bioscience Clinical Development VII A/S
MOUs
Radius Health, Inc.
Biotechnology
2012
Letter of Intent for Clinical Trial Services between Radius Health, Inc. and Nordic Bioscience A/S
MOUs
Radius Health, Inc.
Biotechnology
2012
Capstone Therapeutics 2011 Operating Update and Financial Results Announcement
MOUs
Capstone Therapeutics Corp.
Biotechnology
2012
Letter of Intent Between Lonza Walkersville, Inc. and Genesis Biopharma, Inc. for Process Development and Manufacturing Services
MOUs
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
DE
2011
Letter of Intent Between Sigma-Tau Pharmaceuticals Inc. and DOR BioPharma Inc. Regarding orBec® and Related Products
MOUs
SOLIGENIX, INC.
Biotechnology
2008
Letter of Intent Between Health Source Technologies, Inc. and Joe Brown Regarding Salicinium Product Development
MOUs
HST Global, Inc.
Biotechnology
2008
Memorandum of Understanding Termination Letter between Momenta Pharmaceuticals, Inc. and Sandoz AG
MOUs
Momenta Pharmaceuticals, Inc.
Biotechnology
2007
Letter of Intent Between DOR BioPharma, Inc. and Sigma-Tau Pharmaceuticals, Inc. (January 2007)
MOUs
SOLIGENIX, INC.
Biotechnology
2007
Memorandum of Understanding between Sandoz AG and Momenta Pharmaceuticals, Inc. for Collaborative Development of Generic Injectable Drugs
MOUs
Momenta Pharmaceuticals, Inc.
Biotechnology
NY
2006
Memorandum of Agreement between Optical Molecular Imaging, Inc. and Dr. John Yu Regarding Vaccine Technology Licensing and Employment
MOUs
ImmunoCellular Therapeutics, Ltd.
Biotechnology
CA
2006
Memorandum of Understanding Between Hemispherx Biopharma, Inc. and Fujisawa Deutschland GmbH Regarding Ampligen Distribution Rights
MOUs
HEMISPHERX BIOPHARMA INC
Biotechnology
2004
Amendment No. 2 to Letter of Intent between Xcyte Therapies, Inc. and Taiwan Cell Therapy Company
MOUs
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2003
Amendment No. 1 to Letter of Intent between Xcyte Therapies, Inc. and Taiwan Cell Therapy Company
MOUs
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2003
Master Agreement between Isis Pharmaceuticals, Inc. and Antisense Therapeutics Ltd. Regarding Collaboration, Licensing, and Stock Purchase
MOUs
IONIS PHARMACEUTICALS INC
Biotechnology
2002